Cellular and Molecular Life Sciences

, Volume 64, Issue 24, pp 3233–3247 | Cite as

Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer

Hypoxia and breast cancer: prognostic and therapeutic implications
  • K. Lundgren
  • C. Holm
  • G. LandbergEmail author
Multi-author Review


Hypoxia affects many important processes in tumour progression and is a key feature in the tumour microenvironment that needs to be taken into account when evaluating prognostics and therapeutic options for cancer patients. Hypoxia-regulating proteins, i.e. hypoxia inducible factors (HIFs), and associated gene products have been linked to certain tumour behaviours and might be useful as prognostic and predictive markers. Recently, hypoxia-driven gene products have been launched as novel cancer treatment targets with the potential to increase tumour-specific effects. Breast cancer consists of a multitude of different diseases with certain common characteristics, but also clearly disparate behaviours and genetic alterations. In this review we will summarise the role of hypoxia in breast cancer and specifically outline the importance of hypoxia and HIF-1α regarding prognostic and treatment-specific implications. (Part of a Multi-author Review)


Breast cancer HIF-1α hypoxia prognosis treatment 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag, Basel 2007

Authors and Affiliations

  1. 1.Center for Molecular Pathology, Department of Laboratory MedicineLund University, Malmö University HospitalMalmöSweden

Personalised recommendations